Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Return on Sales (2020 - 2025)

RxSight's Return on Sales history spans 6 years, with the latest figure at 0.28% for Q4 2025.

  • For Q4 2025, Return on Sales fell 81.0% year-over-year to 0.28%; the TTM value through Dec 2025 reached 0.29%, down 29.0%, while the annual FY2025 figure was 0.29%, 29.0% down from the prior year.
  • Return on Sales reached 0.28% in Q4 2025 per RXST's latest filing, up from 0.32% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 3.91% in Q4 2021 to a low of 2.75% in Q2 2021.
  • Average Return on Sales over 5 years is 0.62%, with a median of 0.45% recorded in 2023.
  • The largest YoY upside for Return on Sales was 670bps in 2021 against a maximum downside of -954bps in 2021.
  • A 5-year view of Return on Sales shows it stood at 3.91% in 2021, then crashed by -125bps to 0.97% in 2022, then skyrocketed by 67bps to 0.32% in 2023, then soared by 266bps to 0.53% in 2024, then crashed by -153bps to 0.28% in 2025.
  • Per Business Quant, the three most recent readings for RXST's Return on Sales are 0.28% (Q4 2025), 0.32% (Q3 2025), and 0.35% (Q2 2025).